AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Net Block History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Block | ₹17,407 Cr | ₹14,794 Cr | ₹14,493 Cr | ₹11,024 Cr | ₹10,532 Cr |
What is the latest Net Block ratio of AUROBINDO PHARMA ?
| Year | Net Block |
|---|---|
| Mar2026 | ₹17,407 Cr |
| Mar2025 | ₹14,794 Cr |
| Mar2024 | ₹14,493 Cr |
| Mar2023 | ₹11,024 Cr |
| Mar2022 | ₹10,532 Cr |
How is Net Block of AUROBINDO PHARMA Trending?
| Years | Net Block | % Change | |
|---|---|---|---|
| Mar2026 | ₹17,407 Cr | 17.66 | |
| Mar2025 | ₹14,794 Cr | 2.08 | |
| Mar2024 | ₹14,493 Cr | 31.47 | |
| Mar2023 | ₹11,024 Cr | 4.67 | |
| Mar2022 | ₹10,532 Cr | - | |
Compare Net Block of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹95,890.4 Cr | -3.1% | -1.4% | 56% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,679.0 Cr | -1.8% | -7% | 14.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,408.0 Cr | -3.4% | 0.4% | 58.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,634.0 Cr | -2.7% | -3.6% | 36% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | -3.9% | -4.7% | -10.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,166.0 Cr | 3% | 6.1% | -3.8% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -3.1% |
-1.4% |
56% |
| SENSEX | -3.1% |
-6.2% |
-11.7% |
You may also like the below Video Courses